• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放疗对食管鳞状细胞癌患者淋巴细胞的影响及其临床意义

Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance.

作者信息

Tian Xiufang, Hou Yong, Guo Jianping, Wu Haiyan, Nie Limin, Wang Hang, Zhang Yan, Lv Yajuan

机构信息

Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, Shandong, China.

Department of Oncology, Maternal and Child Health Care Hospital of Zibo, Zibo, Shandong, China.

出版信息

Front Oncol. 2023 Mar 7;13:1096386. doi: 10.3389/fonc.2023.1096386. eCollection 2023.

DOI:10.3389/fonc.2023.1096386
PMID:36959779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10028288/
Abstract

BACKGROUND

Radiotherapy usually leads to a decrease in the total number of lymphocytes in patients with esophageal cancer. The factors that causing lymphopenia and the clinical significance of lymphopenia are studied in this article.

PATIENTS AND METHODS

110 patients with esophageal squamous cell carcinoma who had undergo intensity-modulated radiation therapy were enrolled. Statistical methods were used to analyze the correlation between lymphopenia and total survival in patients with esophageal cancer during radiotherapy, and analyze the correlations between nutritional factors and lymphopenia.

RESULTS

There were 11 patients with the lowest lymphocyte value with level 1-2 during radiotherapy, accounting for 10% of all the patients, and 110 patients with level 3-4, accounting for 90% of all the patient. In all the enrolled patients, the incidence of lymphocyte nadir G1, G2, G3 and G4 MinALC during radiotherapy accounted for 0.91%, 9.09%, 62.73% and 27.27%, respectively.KM survival analysis showed that the overall survival of patients in the group (MinALC ≤ 0.41×10/L) was significantly lower than that of the patients in the other group (MinALC>0.43×10/L). Nutritional indicators were positively correlated with the decline degree of lymphocytes. The minimal value of lymphocyte can predict the occurrence of grade 3-4 radiation pneumonitis.

CONCLUSION

Lymphopenia induced by radiotherapy can predict survival and radiation pneumonitis. Nutritional factors such as hemoglobin and albumin were positively correlated with total lymphocytes numbers induced by radiotherapy.

摘要

背景

放射治疗通常会导致食管癌患者淋巴细胞总数减少。本文研究了导致淋巴细胞减少的因素及淋巴细胞减少的临床意义。

患者与方法

纳入110例行调强放射治疗的食管鳞状细胞癌患者。采用统计学方法分析食管癌患者放疗期间淋巴细胞减少与总生存的相关性,以及营养因素与淋巴细胞减少的相关性。

结果

放疗期间淋巴细胞值最低为1 - 2级的患者有11例,占所有患者的10%,3 - 4级的患者有110例,占所有患者的90%。在所有纳入患者中,放疗期间淋巴细胞最低点G1、G2、G3和G4的最小绝对淋巴细胞计数(MinALC)发生率分别为0.91%、9.09%、62.73%和27.27%。Kaplan - Meier生存分析显示,MinALC≤0.41×10⁹/L组患者的总生存明显低于另一组(MinALC>0.43×10⁹/L)。营养指标与淋巴细胞下降程度呈正相关。淋巴细胞最小值可预测3 - 4级放射性肺炎的发生。

结论

放疗引起的淋巴细胞减少可预测生存和放射性肺炎。血红蛋白和白蛋白等营养因素与放疗诱导的总淋巴细胞数量呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa2/10028288/672e8e46c324/fonc-13-1096386-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa2/10028288/81901c132ce5/fonc-13-1096386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa2/10028288/3bdb012a4a06/fonc-13-1096386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa2/10028288/672e8e46c324/fonc-13-1096386-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa2/10028288/81901c132ce5/fonc-13-1096386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa2/10028288/3bdb012a4a06/fonc-13-1096386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa2/10028288/672e8e46c324/fonc-13-1096386-g003.jpg

相似文献

1
Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance.调强放疗对食管鳞状细胞癌患者淋巴细胞的影响及其临床意义
Front Oncol. 2023 Mar 7;13:1096386. doi: 10.3389/fonc.2023.1096386. eCollection 2023.
2
Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.根治性放化疗期间食管鳞癌患者的淋巴细胞减少症:与剂量学参数和患者结局的关系。
Oncologist. 2021 Mar;26(3):e425-e434. doi: 10.1002/onco.13533. Epub 2020 Oct 6.
3
Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.放疗引起的淋巴细胞减少与鼻咽癌患者的生存相关:治疗方式和基线淋巴细胞计数的影响。
Radiat Oncol. 2020 Mar 14;15(1):65. doi: 10.1186/s13014-020-01494-7.
4
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study.同期加量调强放疗与标准剂量调强放疗治疗局部晚期食管鳞癌的疗效和安全性比较:一项回顾性研究。
Strahlenther Onkol. 2022 Sep;198(9):802-811. doi: 10.1007/s00066-021-01894-y. Epub 2022 Jan 14.
5
Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.同期厄洛替尼和放疗治疗不耐受放化疗的食管鳞癌患者:一项初步研究结果。
Dis Esophagus. 2013 Jul;26(5):503-9. doi: 10.1111/j.1442-2050.2012.01380.x. Epub 2012 Aug 2.
6
Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.放化疗后淋巴细胞最低点与食管癌生存结局
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):128-135. doi: 10.1016/j.ijrobp.2017.05.037. Epub 2017 Jun 1.
7
Lymphopenia during radiotherapy in patients with oropharyngeal cancer.头颈部癌症患者放疗期间的淋巴细胞减少症。
Radiother Oncol. 2020 Apr;145:95-100. doi: 10.1016/j.radonc.2019.12.023. Epub 2020 Jan 10.
8
Survival analysis of 80 elderly patients with esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy with S-1.80 例老年食管鳞癌患者接受 S-1 根治性同期放化疗的生存分析
Cancer Radiother. 2022 Nov;26(8):1064-1069. doi: 10.1016/j.canrad.2022.04.007. Epub 2022 Jul 19.
9
Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A analysis of a randomized controlled trial.根治性食管切除术后IIB-III期患者在术后放疗或放化疗期间发生严重放射性淋巴细胞减少预后较差:一项随机对照试验分析
Front Oncol. 2022 Sep 8;12:936684. doi: 10.3389/fonc.2022.936684. eCollection 2022.
10
[Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)].同步整合加量放疗在不可手术食管癌中的长期疗效及安全性:一项多中心回顾性数据分析(3JECROG R-05)
Zhonghua Zhong Liu Za Zhi. 2021 Aug 23;43(8):889-896. doi: 10.3760/cma.j.cn112152-20190412-00234.

引用本文的文献

1
Predictive significance of the hemoglobin, albumin, lymphocyte, and platelet score for radiation pneumonitis in lung cancer patients: a respective comparative study with dosimetric parameters.血红蛋白、白蛋白、淋巴细胞及血小板评分对肺癌患者放射性肺炎的预测意义:与剂量学参数的各自比较研究
Front Oncol. 2025 Jun 4;15:1605094. doi: 10.3389/fonc.2025.1605094. eCollection 2025.
2
Prognostic Significance of Dynamic Lymphocyte Changes in Esophageal Cancer Patients Receiving Fluorouracil-Cisplatin Combined with Radiotherapy: A Systematic Review and Meta-Analysis.接受氟尿嘧啶-顺铂联合放疗的食管癌患者动态淋巴细胞变化的预后意义:一项系统评价和荟萃分析
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251341431. doi: 10.1177/15330338251341431. Epub 2025 May 19.
3

本文引用的文献

1
Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma.基于循环淋巴细胞亚群的列线图预测食管鳞癌放射性肺炎。
Front Immunol. 2022 Aug 29;13:938795. doi: 10.3389/fimmu.2022.938795. eCollection 2022.
2
Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors.肺癌患者接受调强放疗(HT)与调强适形放疗(IMRT)治疗后的放射性肺炎比较以及循环淋巴细胞亚群作为预测风险因素的研究
J Inflamm Res. 2021 Aug 28;14:4205-4215. doi: 10.2147/JIR.S328955. eCollection 2021.
3
Construction and Verification of a Radiation Pneumonia Prediction Model Based on Multiple Parameters.
Evolving Therapeutic Strategies in Esophageal Squamous Cell Carcinoma: Advances and Perspectives.食管鳞状细胞癌不断发展的治疗策略:进展与展望
J Cancer Prev. 2024 Dec 30;29(4):99-104. doi: 10.15430/JCP.24.026.
4
Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy.心包放疗剂量可能与 4 级淋巴细胞减少症密切相关,并影响接受根治性同步放化疗的局部晚期食管癌患者的预后。
Thorac Cancer. 2023 Sep;14(27):2735-2744. doi: 10.1111/1759-7714.15057. Epub 2023 Jul 30.
基于多参数构建并验证放射性肺炎预测模型。
Cancer Control. 2021 Jan-Dec;28:10732748211026671. doi: 10.1177/10732748211026671.
4
Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy.建立并验证一个预测模型,用于预测接受放疗的食管癌患者出现症状性放射性肺炎的风险。
Med Sci Monit. 2021 May 6;27:e930515. doi: 10.12659/MSM.930515.
5
Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation.淋巴细胞和 T 淋巴细胞亚群的早期变化与接受胸部照射的肺癌患者和实验小鼠的放射性肺炎有关。
Cancer Med. 2020 May;9(10):3437-3444. doi: 10.1002/cam4.2987. Epub 2020 Mar 24.
6
The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy.免疫细胞有效剂量对放化疗后食管癌患者淋巴细胞减少症及生存的影响。
Radiother Oncol. 2020 May;146:180-186. doi: 10.1016/j.radonc.2020.02.015. Epub 2020 Mar 19.
7
Esophageal carcinoma: Towards targeted therapies.食管癌:迈向靶向治疗。
Cell Oncol (Dordr). 2020 Apr;43(2):195-209. doi: 10.1007/s13402-019-00488-2. Epub 2019 Dec 17.
8
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram.预测食管癌放化疗期间严重淋巴细胞减少症:预处理列线图的建立与验证。
Pract Radiat Oncol. 2020 Jan-Feb;10(1):e16-e26. doi: 10.1016/j.prro.2019.07.010. Epub 2019 Jul 29.
9
Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.食管癌患者的淋巴细胞减少症:与营养不良、各种疾病参数及同步放化疗反应的关系。
Oncologist. 2019 Aug;24(8):e677-e686. doi: 10.1634/theoncologist.2018-0723. Epub 2019 Apr 30.
10
Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.克服联合放化疗抵抗:聚焦肿瘤微环境中的贡献途径。
Front Immunol. 2019 Jan 31;9:3154. doi: 10.3389/fimmu.2018.03154. eCollection 2018.